We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its
new corporate branding to clearly mark its strategic evolution to a product-focused
drug development company with a robust pipeline of novel clinical candidates.
Pharma major Cipla has launched "MOBIX" capsules and topical cream
for treatment of osteoarthritis and rheumatoid arthritis under a technical collaboration
with Cymbiotics of San Diego, USA.
NeoPharm has announced that Nippon Kayaku has signed
an exclusive license agreement with NeoPharm for the Japanese development rights
for IL13-PE38QQR, generically known as cintredekin besudotox, which is NeoPharm's
lead drug candidate for the treatment of glioblastoma multiforme (GBM).
Drug giant Pfizer will provide up to $35 million worth of medicines and financial
aid to help the victims of the recent earthquake and tsunami that have devastated
countries in Asia and along the east coast of Africa.
A federal court has ordered the operators of a prescription drug importation
enterprise to send letters to customers notifying them that the business is
illegal and that the safety, purity and efficacy of products sold by the company
cannot be assured, according to the FDA.
A Democratic congressman believes momentum is building for his bipartisan legislation
that would allow the HHS secretary to negotiate drug prices under the Medicare
prescription drug bill, according to a congressional aide.
The FDA is searching for volunteers to participate in an agency pilot project
to evaluate the Study Data Tabulation Model (SDTM) and Implementation Guide
that sponsors of human-drug clinical trials can use to submit data to the agency.
While the Union Government issued Patents Ordinance fulfilling obligations and
commitments under the TRIPS Agreement, which has opened the product patent regime
in pharmaceuticals, food and agro-chemicals, the country's pharmaceutical industry
including large, medium and small sectors is disappointed to find that some
crucial points have either been left out or have been treated in a half hearted
manner in the Ordinance.
Ness Technologies, a global provider of information technology services, has
been engaged by Wockhardt Pharmaceuticals of Mumbai, India to install, configure,
customize, host and support Wockhardt Pharmaceuticals' U.S.-based financial
IT infrastructure, including all financial modules, electronic data interchange,
and interfaces to Wockhardt Pharmaceuticals' contract and procurement management
systems.